Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Tumors

Highlights

A collection of news and information related to Tumors published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-12 of 334
» View latimes.com items only
    Jul 18, 2011 |Story| Los Angeles Times
  1. Good dogs: The list

    They're more than man's best friends: They're friends with benefits. Here are a few ways dogs are helping to make our lives healthier, safer and longer.
    They're more than man's best friends: They're friends with benefits. Here are a few ways dogs are helping to make our lives healthier, safer and longer. Search and rescue: When disaster strikes, search-and-rescue dogs are never far behind. After the...

    Tags: Japan Earthquake and Tsunami (2011), Natural Disasters, Skin Cancer, Research, Medical Research

  2. Jul 28, 2011 |Story| Los Angeles Times
  3. Cellphones, kids and cancer: Don't worry, be happy?

    The first-ever study comparing brain cancer incidence in kids who use cellphones with those who do not has found no difference, suggesting that children's long-feared vulnerability to brain cancer with early cellphone use does not exist.
    The first-ever study comparing brain cancer incidence in kids who use cellphones with those who do not has found no difference, suggesting that children's long-feared vulnerability to brain cancer with early cellphone use does not exist. In a four-...

    Tags: Science and Technology, Medical Research, Cancer, Human Body, Brain

  4. Aug 7, 2011 |Story| Los Angeles Times
  5. Baruj Benacerraf dies at 90; Nobelist made key discoveries about immune system

    Dr. Baruj Benacerraf, who shared the 1980 Nobel Prize in physiology or medicine for his pioneering work explaining why some people are able to fight off infections and tumors while others are not, died Tuesday at his Boston home. He was 90.
    Dr. Baruj Benacerraf, who shared the 1980 Nobel Prize in physiology or medicine for his pioneering work explaining why some people are able to fight off infections and tumors while others are not, died Tuesday at his Boston home. He was 90. The cause was...

    Tags: Research, Medical Research, Elections, Columbia University, Science and Technology

  6. Apr 27, 2010 |Story| Los Angeles Times
  7. Test linked to fewer colorectal cancer deaths

    A single sigmoidoscopy between ages 55 and 64 can reduce deaths from colorectal cancer by at least 43%, British researchers reported Tuesday. The results from the first large randomized trial of sigmoidoscopy show that it is a more effective tool than...

    Tags: Colon, Medical Procedures and Tests, Trials, University of California, Los Angeles, Health Organizations

  8. Jul 6, 2009 |Story| Los Angeles Times
  9. A cancer cocktail's edge

    Even if a vaccine produces an appropriate cancer-attacking immune response, it still may not be enough to achieve clinical benefit, especially in patients with very advanced disease.
    Special to the Los Angeles Times
    Even if a vaccine produces an appropriate cancer-attacking immune response, it still may not be enough to achieve clinical benefit, especially in patients with very advanced disease. This could be because the ability of large tumors to suppress the...

    Tags: Vaccines, Trials, Skin Cancer, Crime, Law and Justice, Cancer

  10. Jul 6, 2009 |Story| Los Angeles Times
  11. Coming soon in the medical arsenal against cancer: vaccines

    It's a deceptively simple idea: What if doctors could recruit the body's own immune system to fight cancer? The complexities of the immune system have kept this from becoming reality, until now. Three cancer vaccines -- for prostate cancer, melanoma and lymphoma -- have achieved positive results in so-called Phase 3 clinical trials -- the kind of studies that the Food and Drug Administration requires for a medicine to gain approval.
    Los Angeles Times Staff Writer
    It's a deceptively simple idea: What if doctors could recruit the body's own immune system to fight cancer? The complexities of the immune system have kept this from becoming reality, until now. Three cancer vaccines -- for prostate cancer, melanoma and...

    Tags: Leukemia, Vaccines, Trials, Skin Cancer, University of California, Los Angeles

  12. Sep 22, 2010 |Story| Los Angeles Times
  13. FDA approves first oral drug to slow multiple sclerosis progression

    A failed anti-rejection drug got a new purpose and a new lease on commercial life Wednesday as the Food and Drug Administration approved the medication fingolimod -- to be marketed as Gilenya -- to slow the progression of disability in multiple...

    Tags: Multiple Sclerosis, Trials, Nervous System, Crime, Law and Justice, Human Body

  14. Nov 21, 2009 |Story| Los Angeles Times
  15. Cancer screening: What could it hurt? A lot, actually

    It seemed like a good idea at the time.
    It seemed like a good idea at the time. In 1984, Japan began screening the urine of 6-month-old infants for neuroblastoma, the most common type of solid tumor in young children. The test was simple and could show signs of cancer long before clinical...

    Tags: Medical Procedures and Tests, Medical Research, Health Organizations, Prostate, Social Issues

  16. Jul 27, 2010 |Story| Los Angeles Times
  17. Many men with low-risk prostate cancer overtreated, study finds

    About three-quarters of men with low-risk prostate tumors that can safely be ignored for months or years receive aggressive treatment, despite the risk of complications, researchers reported Monday. The findings, published in the Archives of Internal...

    Tags: Medical Research, Cancer, Prostate, Radiation Therapy, Diseases and Illnesses

  18. Jan 18, 2010 |Story| Los Angeles Times
  19. Therapies' benefits unclear

    In a quest to look younger, be healthier and feel more vital later in life, increasing numbers of men, just like Jeffry Life, are turning to testosterone and human growth hormone. Use of both hormones is controversial. Read on:
    Los Angeles Times
    In a quest to look younger, be healthier and feel more vital later in life, increasing numbers of men, just like Jeffry Life, are turning to testosterone and human growth hormone. Use of both hormones is controversial. Read on: Testosterone: "Older men ....

    Tags: IMS Health Incorporated, Aging, Diabetes, Medical Research, Sleep Apnea

  20. Jan 10, 2010 |Story| Los Angeles Times
  21. Grant money could speed stem cell cures

    Dr. Karen Aboody estimates that she has cured several hundred mice of a cancer of the central nervous system called neuroblastoma.
    Dr. Karen Aboody estimates that she has cured several hundred mice of a cancer of the central nervous system called neuroblastoma. First she injected them with specialized neural stem cells that naturally zero in on the tumors and surround them. Then she...

    Tags: Science, University of Southern California, Diabetes, Trials, Research

  22. Aug 28, 2009 |Story| Los Angeles Times
  23. Junipero Serra needs just one more miracle

    In a basement at Old Mission Santa Barbara, a filing cabinet is thick with claims of miracles that didn't make the grade.
    In a basement at Old Mission Santa Barbara, a filing cabinet is thick with claims of miracles that didn't make the grade. A man falls off his horse and, thanks to Junipero Serra, he gets up unscathed. A woman visits Serra's tomb in Carmel and something...

    Tags: Christianity, Science, Skull, U.S. Air Force, Science and Technology

 1  2 3 4 5 6 7 8 9 10 11-28Next >
Advertisement
Loading...
 
 

Date:

Credit:

User-submitted

Tags:

Rate:
Sending...

E-mail this photo

Error: malformed email address(es)
Both "from" and "recipient" email fields are required.

Recipient E-mail Addresses

(up to 3, separated by commas) Send me a copy.

From:

e-mail | buy this photo | link to photo
Tumors Photos
Christian Stilwell, 17, of Algonquin, who died in his s...
(June 13, 2011)
Christian Stilwell
Exemestane, sold as Aromasin, can reduce the risk of tu...
(June 10, 2011)
Drug cuts breast cancer risk for some post-menopausal women
PLX4032, or vemurafenib, is the first chemotherapy agen...
(June 10, 2011)
New drugs show promise in treating deadly melanoma